Anti-diabetic medicine reduces risks of heart and kidney diseases

Tuesday, 13 June 2017

A new anti-diabetic drug, known for reducing blood sugar levels in people with type-2 diabetes, proved to be successful in reducing the risk of cardiovascular disease, according to a recent study published in the New England Journal of Medicine in the Unites States. Conducted in 30 countries and on more than 10,000 patients, the clinical experiment showed that the oral drug, known as Invokana (canagliflozin), reduced the risk of hospitalization due to heart failure for those affected by diabetes ...

Saudi couple help develop treatment for diabetes and obesity

Sunday, 22 May 2016

Alaa Shafie and his wife Amal Ashour are part of the team at the University of Warwick, United Kingdom, who made the breakthrough

How are we doing?

How are we doing?

Name Name *
Email Email *
Country Country
Message Message *
Maximum 550 words allowed